Intravenous immune globulin for recurrent fetal loss.
D000026:Abortion, Habitual / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D017152:Antibodies, Antiphospholipid / Q000009:adverse effects; D054598:Blue Cross Blue Shield Insurance Plans; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care; D011247:Pregnancy; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration